[Ocular involvement during prolonged treatment with neuroleptics].
D000328:Adult; D000368:Aged; D002746:Chlorpromazine / Q000009:adverse effects* / Q000627:therapeutic use; D003318:Corneal Opacity / Q000139:chemically induced*; D005128:Eye Diseases / Q000139:chemically induced; D005260:Female; D005654:Fundus Oculi; D006801:Humans; D007908:Lens, Crystalline; D008134:Long-Term Care; D008297:Male; D008548:Melanosis / Q000139:chemically induced*; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000009:adverse effects* / Q000627:therapeutic use; D014792:Visual Acuity
D014149:Tranquilizing Agents; D002746:Chlorpromazine
Les atteintes oculaires au cours de traitements prolongés auz neuroleptiques.